Pancreatic Cancer Lawsuits Over Januvia, Byetta and Victoza Not Set For Bellwether Trials Until 2020
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.
U.K. regulators say Actemra is unfit for use in the treatment of giant cell arthritis because it is too expensive.
The FDA has expanded the use of Actemra for the treatment of side effects of CAR-T cell therapy amid growing concerns over the drug's potential side effects.
The FDA warns that at least five patient deaths have been linked to complications with intragastric weight loss balloons and investigators are still trying to ascertain the cause of those…
Actemra is being tested in an ongoing clinical trial as a potential treatment for systemic sclerosis, despite growing concerns linking the drug to heart attacks, strokes, and deaths.
A new study looking at the use of Actemra to treat giant cell arthritis indicates that 15% of patients could suffer severe side effects.
New research indicates that some patients taking Actemra to treat rheumatoid arthritis may be more susceptible to severe infections than others.
The FDA warns that the IBS drug Viberzi has been linked to cases of serious pancreatitis in patients who do not have a gallbladder, and may have caused at least…
The FDA warns that surgical balloons implanted in the stomach to promote weight loss can overinflate and could also cause cases of acute pancreatitis.